Differential Effects of d-Sotalol on Subendocardial Purkinje Myocytes Isolated from Normal or 10 to 14 Days Postinfarction Canine Hearts: Role of Extracellular Potassium Concentration
Electrophysiologic properties of surviving Purkinje cardiomyocytes in the late postmyocardial-infarction phase are not well established. By using standard microelectrode techniques, we evaluated the effects of the class III agent d-sotalol on action potential parameters of single Purkinje cardiomyoc...
Gespeichert in:
Veröffentlicht in: | Journal of cardiovascular pharmacology 1998-08, Vol.32 (2), p.274-283 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 283 |
---|---|
container_issue | 2 |
container_start_page | 274 |
container_title | Journal of cardiovascular pharmacology |
container_volume | 32 |
creator | Marschang, Harald Schöls, Wolfgang Karolyi, Laszlo Beyer, Thorsten Kübler, Wolfgang Brachmann, Johannes |
description | Electrophysiologic properties of surviving Purkinje cardiomyocytes in the late postmyocardial-infarction phase are not well established. By using standard microelectrode techniques, we evaluated the effects of the class III agent d-sotalol on action potential parameters of single Purkinje cardiomyocytes isolated from normal canine hearts or those 10-14 days after infarction. Measurements were obtained at 2.5, 3.5, and 6 mM extracellular potassium concentrations. Action-potential parameters recorded at baseline did not differ significantly between normal and infarct-surviving Purkinje cardiomyocytes. At 3.5 and 6 mM extracellular potassium concentrations, surviving Purkinje cells appeared to be more sensitive to the effects of d-sotalol than normal Purkinje cells. In contrast, at 2.5 mM extracellular potassium concentration, the differential responses of normal and infarctsurviving Purkinje cells to d-sotalol was abolished. Reverse rate dependence was more prominent in normal than in postinfarction Purkinje cells, independent of the extracellular potassium concentration studied. The previously described enhanced sensitivity of subacutely infarcted tissue to class III agents seems to persist on a cellular level 10-14 days after myocardial infarction, even after full normalization of baseline action-potential parameters. Differential membrane-regulation mechanisms, dependent on the extracellular potassium concentrations, may account for the increased susceptibility to antiarrhythmia agents in the late postinfarction phase. |
doi_str_mv | 10.1097/00005344-199808000-00015 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_80062348</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>80062348</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5005-d5fccbe5643d36020161c5c8c602a9e39001900e4ebb2624ceca463989f0dbda3</originalsourceid><addsrcrecordid>eNp1UsFu1DAQtRCoLIVPQPIBcQs4sZONuaHtllYqUFE4WxNnrLp17GI7Kvtl_B4Ou-wNSyOPNe_NjN4zIbRm72om1-9ZOS0Xoqql7FlfXlWJun1CVnXLeSVYw5-SFas7VjVCdM_Ji5TuCkK06-6EnMg1Y1KyFfl9Zo3BiD5bcHRbcp0TDYaO1U3I4IKjwdObeUA_Bg1xXGDXc7y3_g7p513Qu4yJXqbgIONITQwT_RLiVGAhln1pDrQW9Ax2iV6HlK03EHW2pesGvPVILxBiTh_ot-Bwmbz9lSNodG52EAsnQ0p2nugmeF32jLCQX5JnBlzCV4f7lPw4337fXFRXXz9dbj5eVbotClVja7QesO0EH3nHmiJIrVvd65KDRC6LJCVQ4DA0XSM0ahAdl700bBxG4Kfk7b7vQww_Z0xZTTYty4HHMCdVpO8aLvoC7PdAHUNKEY16iHaCuFM1U4tn6p9n6uiZ-utZob4-zJiHCccj8WBSqb851CFpcCaC1zYdYY3g_VqKAhN72GNwGWO6d_MjRnWL4PKt-t-P4X8A4Dmwuw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>80062348</pqid></control><display><type>article</type><title>Differential Effects of d-Sotalol on Subendocardial Purkinje Myocytes Isolated from Normal or 10 to 14 Days Postinfarction Canine Hearts: Role of Extracellular Potassium Concentration</title><source>MEDLINE</source><source>Journals@Ovid LWW Legacy Archive</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Journals@Ovid Complete</source><creator>Marschang, Harald ; Schöls, Wolfgang ; Karolyi, Laszlo ; Beyer, Thorsten ; Kübler, Wolfgang ; Brachmann, Johannes</creator><creatorcontrib>Marschang, Harald ; Schöls, Wolfgang ; Karolyi, Laszlo ; Beyer, Thorsten ; Kübler, Wolfgang ; Brachmann, Johannes</creatorcontrib><description>Electrophysiologic properties of surviving Purkinje cardiomyocytes in the late postmyocardial-infarction phase are not well established. By using standard microelectrode techniques, we evaluated the effects of the class III agent d-sotalol on action potential parameters of single Purkinje cardiomyocytes isolated from normal canine hearts or those 10-14 days after infarction. Measurements were obtained at 2.5, 3.5, and 6 mM extracellular potassium concentrations. Action-potential parameters recorded at baseline did not differ significantly between normal and infarct-surviving Purkinje cardiomyocytes. At 3.5 and 6 mM extracellular potassium concentrations, surviving Purkinje cells appeared to be more sensitive to the effects of d-sotalol than normal Purkinje cells. In contrast, at 2.5 mM extracellular potassium concentration, the differential responses of normal and infarctsurviving Purkinje cells to d-sotalol was abolished. Reverse rate dependence was more prominent in normal than in postinfarction Purkinje cells, independent of the extracellular potassium concentration studied. The previously described enhanced sensitivity of subacutely infarcted tissue to class III agents seems to persist on a cellular level 10-14 days after myocardial infarction, even after full normalization of baseline action-potential parameters. Differential membrane-regulation mechanisms, dependent on the extracellular potassium concentrations, may account for the increased susceptibility to antiarrhythmia agents in the late postinfarction phase.</description><identifier>ISSN: 0160-2446</identifier><identifier>EISSN: 1533-4023</identifier><identifier>DOI: 10.1097/00005344-199808000-00015</identifier><identifier>PMID: 9700990</identifier><identifier>CODEN: JCPCDT</identifier><language>eng</language><publisher>Philadelphia, PA: Lippincott-Raven Publishers</publisher><subject>Action Potentials - drug effects ; Animals ; Anti-Arrhythmia Agents - pharmacology ; Biological and medical sciences ; Cardiovascular system ; Cells, Cultured ; Dogs ; Heart - drug effects ; Heart - physiology ; Medical sciences ; Miscellaneous ; Myocardial Infarction - pathology ; Myocardial Infarction - physiopathology ; Myocardium - metabolism ; Pharmacology. Drug treatments ; Potassium - physiology ; Purkinje Fibers - drug effects ; Purkinje Fibers - pathology ; Sotalol - pharmacology</subject><ispartof>Journal of cardiovascular pharmacology, 1998-08, Vol.32 (2), p.274-283</ispartof><rights>Lippincott-Raven Publishers</rights><rights>1998 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5005-d5fccbe5643d36020161c5c8c602a9e39001900e4ebb2624ceca463989f0dbda3</citedby><cites>FETCH-LOGICAL-c5005-d5fccbe5643d36020161c5c8c602a9e39001900e4ebb2624ceca463989f0dbda3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf><![CDATA[$$Uhttp://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&PDF=y&D=ovft&AN=00005344-199808000-00015$$EPDF$$P50$$Gwolterskluwer$$H]]></linktopdf><linktohtml>$$Uhttp://ovidsp.ovid.com/ovidweb.cgi?T=JS&NEWS=n&CSC=Y&PAGE=fulltext&D=ovft&AN=00005344-199808000-00015$$EHTML$$P50$$Gwolterskluwer$$H</linktohtml><link.rule.ids>315,781,785,4610,27928,27929,64670,65465</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=2438794$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9700990$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Marschang, Harald</creatorcontrib><creatorcontrib>Schöls, Wolfgang</creatorcontrib><creatorcontrib>Karolyi, Laszlo</creatorcontrib><creatorcontrib>Beyer, Thorsten</creatorcontrib><creatorcontrib>Kübler, Wolfgang</creatorcontrib><creatorcontrib>Brachmann, Johannes</creatorcontrib><title>Differential Effects of d-Sotalol on Subendocardial Purkinje Myocytes Isolated from Normal or 10 to 14 Days Postinfarction Canine Hearts: Role of Extracellular Potassium Concentration</title><title>Journal of cardiovascular pharmacology</title><addtitle>J Cardiovasc Pharmacol</addtitle><description>Electrophysiologic properties of surviving Purkinje cardiomyocytes in the late postmyocardial-infarction phase are not well established. By using standard microelectrode techniques, we evaluated the effects of the class III agent d-sotalol on action potential parameters of single Purkinje cardiomyocytes isolated from normal canine hearts or those 10-14 days after infarction. Measurements were obtained at 2.5, 3.5, and 6 mM extracellular potassium concentrations. Action-potential parameters recorded at baseline did not differ significantly between normal and infarct-surviving Purkinje cardiomyocytes. At 3.5 and 6 mM extracellular potassium concentrations, surviving Purkinje cells appeared to be more sensitive to the effects of d-sotalol than normal Purkinje cells. In contrast, at 2.5 mM extracellular potassium concentration, the differential responses of normal and infarctsurviving Purkinje cells to d-sotalol was abolished. Reverse rate dependence was more prominent in normal than in postinfarction Purkinje cells, independent of the extracellular potassium concentration studied. The previously described enhanced sensitivity of subacutely infarcted tissue to class III agents seems to persist on a cellular level 10-14 days after myocardial infarction, even after full normalization of baseline action-potential parameters. Differential membrane-regulation mechanisms, dependent on the extracellular potassium concentrations, may account for the increased susceptibility to antiarrhythmia agents in the late postinfarction phase.</description><subject>Action Potentials - drug effects</subject><subject>Animals</subject><subject>Anti-Arrhythmia Agents - pharmacology</subject><subject>Biological and medical sciences</subject><subject>Cardiovascular system</subject><subject>Cells, Cultured</subject><subject>Dogs</subject><subject>Heart - drug effects</subject><subject>Heart - physiology</subject><subject>Medical sciences</subject><subject>Miscellaneous</subject><subject>Myocardial Infarction - pathology</subject><subject>Myocardial Infarction - physiopathology</subject><subject>Myocardium - metabolism</subject><subject>Pharmacology. Drug treatments</subject><subject>Potassium - physiology</subject><subject>Purkinje Fibers - drug effects</subject><subject>Purkinje Fibers - pathology</subject><subject>Sotalol - pharmacology</subject><issn>0160-2446</issn><issn>1533-4023</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1998</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1UsFu1DAQtRCoLIVPQPIBcQs4sZONuaHtllYqUFE4WxNnrLp17GI7Kvtl_B4Ou-wNSyOPNe_NjN4zIbRm72om1-9ZOS0Xoqql7FlfXlWJun1CVnXLeSVYw5-SFas7VjVCdM_Ji5TuCkK06-6EnMg1Y1KyFfl9Zo3BiD5bcHRbcp0TDYaO1U3I4IKjwdObeUA_Bg1xXGDXc7y3_g7p513Qu4yJXqbgIONITQwT_RLiVGAhln1pDrQW9Ax2iV6HlK03EHW2pesGvPVILxBiTh_ot-Bwmbz9lSNodG52EAsnQ0p2nugmeF32jLCQX5JnBlzCV4f7lPw4337fXFRXXz9dbj5eVbotClVja7QesO0EH3nHmiJIrVvd65KDRC6LJCVQ4DA0XSM0ahAdl700bBxG4Kfk7b7vQww_Z0xZTTYty4HHMCdVpO8aLvoC7PdAHUNKEY16iHaCuFM1U4tn6p9n6uiZ-utZob4-zJiHCccj8WBSqb851CFpcCaC1zYdYY3g_VqKAhN72GNwGWO6d_MjRnWL4PKt-t-P4X8A4Dmwuw</recordid><startdate>199808</startdate><enddate>199808</enddate><creator>Marschang, Harald</creator><creator>Schöls, Wolfgang</creator><creator>Karolyi, Laszlo</creator><creator>Beyer, Thorsten</creator><creator>Kübler, Wolfgang</creator><creator>Brachmann, Johannes</creator><general>Lippincott-Raven Publishers</general><general>Lippincott</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>199808</creationdate><title>Differential Effects of d-Sotalol on Subendocardial Purkinje Myocytes Isolated from Normal or 10 to 14 Days Postinfarction Canine Hearts: Role of Extracellular Potassium Concentration</title><author>Marschang, Harald ; Schöls, Wolfgang ; Karolyi, Laszlo ; Beyer, Thorsten ; Kübler, Wolfgang ; Brachmann, Johannes</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5005-d5fccbe5643d36020161c5c8c602a9e39001900e4ebb2624ceca463989f0dbda3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1998</creationdate><topic>Action Potentials - drug effects</topic><topic>Animals</topic><topic>Anti-Arrhythmia Agents - pharmacology</topic><topic>Biological and medical sciences</topic><topic>Cardiovascular system</topic><topic>Cells, Cultured</topic><topic>Dogs</topic><topic>Heart - drug effects</topic><topic>Heart - physiology</topic><topic>Medical sciences</topic><topic>Miscellaneous</topic><topic>Myocardial Infarction - pathology</topic><topic>Myocardial Infarction - physiopathology</topic><topic>Myocardium - metabolism</topic><topic>Pharmacology. Drug treatments</topic><topic>Potassium - physiology</topic><topic>Purkinje Fibers - drug effects</topic><topic>Purkinje Fibers - pathology</topic><topic>Sotalol - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Marschang, Harald</creatorcontrib><creatorcontrib>Schöls, Wolfgang</creatorcontrib><creatorcontrib>Karolyi, Laszlo</creatorcontrib><creatorcontrib>Beyer, Thorsten</creatorcontrib><creatorcontrib>Kübler, Wolfgang</creatorcontrib><creatorcontrib>Brachmann, Johannes</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of cardiovascular pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Marschang, Harald</au><au>Schöls, Wolfgang</au><au>Karolyi, Laszlo</au><au>Beyer, Thorsten</au><au>Kübler, Wolfgang</au><au>Brachmann, Johannes</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Differential Effects of d-Sotalol on Subendocardial Purkinje Myocytes Isolated from Normal or 10 to 14 Days Postinfarction Canine Hearts: Role of Extracellular Potassium Concentration</atitle><jtitle>Journal of cardiovascular pharmacology</jtitle><addtitle>J Cardiovasc Pharmacol</addtitle><date>1998-08</date><risdate>1998</risdate><volume>32</volume><issue>2</issue><spage>274</spage><epage>283</epage><pages>274-283</pages><issn>0160-2446</issn><eissn>1533-4023</eissn><coden>JCPCDT</coden><abstract>Electrophysiologic properties of surviving Purkinje cardiomyocytes in the late postmyocardial-infarction phase are not well established. By using standard microelectrode techniques, we evaluated the effects of the class III agent d-sotalol on action potential parameters of single Purkinje cardiomyocytes isolated from normal canine hearts or those 10-14 days after infarction. Measurements were obtained at 2.5, 3.5, and 6 mM extracellular potassium concentrations. Action-potential parameters recorded at baseline did not differ significantly between normal and infarct-surviving Purkinje cardiomyocytes. At 3.5 and 6 mM extracellular potassium concentrations, surviving Purkinje cells appeared to be more sensitive to the effects of d-sotalol than normal Purkinje cells. In contrast, at 2.5 mM extracellular potassium concentration, the differential responses of normal and infarctsurviving Purkinje cells to d-sotalol was abolished. Reverse rate dependence was more prominent in normal than in postinfarction Purkinje cells, independent of the extracellular potassium concentration studied. The previously described enhanced sensitivity of subacutely infarcted tissue to class III agents seems to persist on a cellular level 10-14 days after myocardial infarction, even after full normalization of baseline action-potential parameters. Differential membrane-regulation mechanisms, dependent on the extracellular potassium concentrations, may account for the increased susceptibility to antiarrhythmia agents in the late postinfarction phase.</abstract><cop>Philadelphia, PA</cop><cop>Hagerstown, MD</cop><pub>Lippincott-Raven Publishers</pub><pmid>9700990</pmid><doi>10.1097/00005344-199808000-00015</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0160-2446 |
ispartof | Journal of cardiovascular pharmacology, 1998-08, Vol.32 (2), p.274-283 |
issn | 0160-2446 1533-4023 |
language | eng |
recordid | cdi_proquest_miscellaneous_80062348 |
source | MEDLINE; Journals@Ovid LWW Legacy Archive; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Journals@Ovid Complete |
subjects | Action Potentials - drug effects Animals Anti-Arrhythmia Agents - pharmacology Biological and medical sciences Cardiovascular system Cells, Cultured Dogs Heart - drug effects Heart - physiology Medical sciences Miscellaneous Myocardial Infarction - pathology Myocardial Infarction - physiopathology Myocardium - metabolism Pharmacology. Drug treatments Potassium - physiology Purkinje Fibers - drug effects Purkinje Fibers - pathology Sotalol - pharmacology |
title | Differential Effects of d-Sotalol on Subendocardial Purkinje Myocytes Isolated from Normal or 10 to 14 Days Postinfarction Canine Hearts: Role of Extracellular Potassium Concentration |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-17T12%3A35%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Differential%20Effects%20of%20d-Sotalol%20on%20Subendocardial%20Purkinje%20Myocytes%20Isolated%20from%20Normal%20or%2010%20to%2014%20Days%20Postinfarction%20Canine%20Hearts:%20Role%20of%20Extracellular%20Potassium%20Concentration&rft.jtitle=Journal%20of%20cardiovascular%20pharmacology&rft.au=Marschang,%20Harald&rft.date=1998-08&rft.volume=32&rft.issue=2&rft.spage=274&rft.epage=283&rft.pages=274-283&rft.issn=0160-2446&rft.eissn=1533-4023&rft.coden=JCPCDT&rft_id=info:doi/10.1097/00005344-199808000-00015&rft_dat=%3Cproquest_cross%3E80062348%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=80062348&rft_id=info:pmid/9700990&rfr_iscdi=true |